Kazuhiko Nakao Selected Research

Kazuhiko Nakao Research Topics

Disease

57	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 03/2002
38	Neoplasms (Cancer) 06/2022 - 05/2002
30	Infections 02/2022 - 08/2002
21	Fibrosis (Cirrhosis) 06/2022 - 08/2002
15	Liver Cirrhosis (Hepatic Cirrhosis) 02/2020 - 09/2003
13	Non-alcoholic Fatty Liver Disease 06/2022 - 07/2002
12	Chronic Hepatitis C 01/2016 - 09/2003
11	Liver Diseases (Liver Disease) 06/2021 - 08/2002
9	Esophageal Achalasia (Megaesophagus) 07/2021 - 01/2013
7	Inflammation (Inflammations) 02/2022 - 06/2003
7	Insulin Resistance 05/2019 - 12/2006
7	Disease Progression 01/2019 - 08/2002
6	Hepatitis C 02/2022 - 05/2002
6	Pathologic Constriction (Stenosis) 01/2021 - 06/2011
6	Esophageal Squamous Cell Carcinoma 06/2011 - 01/2010
5	Fatty Liver 02/2022 - 01/2014
5	Carcinoma (Carcinomatosis) 09/2021 - 11/2012
5	Neoplasm Metastasis (Metastasis) 09/2021 - 05/2002
5	Stomach Neoplasms (Stomach Cancer) 08/2021 - 02/2011
5	Ulcerative Colitis 04/2020 - 01/2012
5	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 07/2004
4	Sarcopenia 01/2022 - 09/2017
4	Reinfection 11/2018 - 09/2009
4	Crohn Disease (Crohn's Disease) 07/2016 - 06/2014
4	Hepatitis B 07/2013 - 04/2005
4	Hepatitis 10/2011 - 06/2002
3	Chronic Hepatitis B 01/2022 - 05/2008
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2021 - 06/2014
3	End Stage Liver Disease 08/2021 - 03/2020
3	Gastroesophageal Reflux (GERD) 02/2021 - 01/2014
3	Brain Diseases (Brain Disorder) 10/2020 - 10/2010
3	Hepatic Encephalopathy 08/2020 - 01/2010
3	Body Weight (Weight, Body) 05/2019 - 11/2015
3	Ulcer 02/2018 - 02/2012
3	Diabetes Mellitus 12/2016 - 06/2003
3	Hemorrhage 01/2016 - 05/2014
3	Thrombosis (Thrombus) 06/2014 - 08/2008
3	Esophageal Stenosis (Esophageal Stricture) 06/2011 - 01/2011
2	Necrosis 01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

20	InterferonsIBA 07/2021 - 06/2002
13	Antiviral Agents (Antivirals)IBA 02/2022 - 06/2002
13	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2010
10	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2003
9	CytokinesIBA 07/2021 - 06/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
8	Alanine Transaminase (SGPT)IBA 01/2019 - 05/2002
8	Ribavirin (Virazole)FDA LinkGeneric 02/2018 - 09/2009
7	Pharmaceutical PreparationsIBA 05/2022 - 04/2004
7	SteroidsIBA 01/2020 - 01/2010
7	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2006
7	RNA (Ribonucleic Acid)IBA 02/2018 - 05/2003
6	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 04/2002
6	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 05/2002
6	Insulin (Novolin)FDA Link 01/2016 - 12/2006
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2014 - 08/2002
6	Prednisolone (Predate)FDA LinkGeneric 03/2014 - 03/2010
5	lenvatinibIBA 05/2022 - 11/2019
5	AcidsIBA 02/2021 - 06/2015
4	oxidized low density lipoproteinIBA 01/2021 - 01/2016
4	AlbuminsIBA 03/2020 - 02/2009
4	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 09/2016
4	Messenger RNA (mRNA)IBA 09/2015 - 02/2012
4	AntigensIBA 07/2013 - 01/2004
4	Interleukin-10 (Interleukin 10)IBA 04/2005 - 06/2002
3	Sorafenib (BAY 43-9006)FDA Link 05/2022 - 09/2017
3	gadolinium ethoxybenzyl DTPA FDA Link 02/2022 - 08/2011
3	Protein Isoforms (Isoforms)IBA 01/2022 - 04/2014
3	Cisplatin (Platino)FDA LinkGeneric 08/2021 - 09/2010
3	geranylgeranylacetone (teprenone)IBA 07/2021 - 02/2012
3	Branched-Chain Amino AcidsIBA 02/2021 - 02/2009
3	LDL CholesterolIBA 01/2021 - 01/2016
3	SofosbuvirIBA 01/2021 - 01/2016
3	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2015
3	BilirubinIBA 03/2020 - 05/2010
3	LipidsIBA 03/2019 - 01/2012
3	asunaprevirIBA 03/2019 - 01/2016
3	daclatasvirIBA 03/2019 - 01/2016
3	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2015
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 06/2011
3	EnzymesIBA 01/2019 - 07/2004
3	Phenobarbital (Luminal)FDA Link 12/2017 - 03/2013
3	Biological ProductsIBA 11/2017 - 01/2010
3	Mesalamine (Mesalazine)FDA LinkGeneric 07/2014 - 03/2010
3	Small Interfering RNA (siRNA)IBA 01/2013 - 05/2003
3	Fetal Proteins (Fetoprotein)IBA 12/2012 - 06/2011
3	Hepatitis B e AntigensIBA 12/2009 - 05/2002
3	NF-kappa B (NF-kB)IBA 09/2006 - 03/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 10/2012
2	Bevacizumab (Avastin)FDA Link 05/2022 - 02/2022
2	atezolizumabIBA 05/2022 - 02/2022
2	Serum AlbuminIBA 04/2022 - 05/2010
2	Hemoglobins (Hemoglobin)IBA 04/2022 - 01/2014
2	Phospholipases (Phospholipase)IBA 02/2022 - 06/2017

Therapy/Procedure

36	Therapeutics 05/2022 - 12/2003
17	Liver Transplantation 06/2022 - 08/2007
6	Transplantation 01/2022 - 08/2007
6	Drug Therapy (Chemotherapy) 08/2021 - 07/2006
5	Myotomy 01/2021 - 01/2013
5	Hepatectomy 10/2011 - 05/2010
3	Stents 01/2022 - 01/2010